Health
Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate – The Guardian
Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
CoronavirusResearchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
Although extremely rare, a blood clot syndrome after the first dose of the Oxford/AstraZeneca vaccine carries a high risk of death…
Continue Reading
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General15 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?